SCHEMBL54889

SCHEMBL54889

O=COc1ccccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 5/20 0.41
TSHR P16473 1/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
ALDH1A1 P00352 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
PKM P14618 1/20 0.39
CXCL8 P10145 1/20 0.39
HTT P42858 2/20 0.37
RXRA P19793 1/20 0.37
RXRB P28702 1/20 0.37
TP53 P04637 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2095443 0.82 ALDH1A1 (0.43) LMNASMN1; SMN2TSHRMEN1KMT2A
SCHEMBL9881101 0.82 ALDH1A1 (0.42) LMNASMN1; SMN2HPGDTSHRMEN1
SCHEMBL28184037 0.79 ALDH1A1 (0.40) LMNASMN1; SMN2HPGDTSHRMEN1
SCHEMBL29068856 0.79 MRGPRX4 (0.41) LMNASMN1; SMN2HPGDMEN1KMT2A
SCHEMBL19983998 0.79 ALDH1A1 (0.42) LMNASMN1; SMN2HPGDMEN1KMT2A
1,2-Dichlorobenzene SCHEMBL28253435 0.77 ALDH1A1 (0.55) LMNAHPGDTSHRKMT2AALDH1A1
SCHEMBL29152933 0.76 SMN1; SMN2 (0.42) LMNASMN1; SMN2HPGDTSHRMEN1
SCHEMBL194684 0.76 ALDH1A1 (0.44) LMNASMN1; SMN2HPGDTSHRMEN1
SCHEMBL29960351 0.76 ALDH1A1 (0.44) LMNASMN1; SMN2HPGDTSHRMEN1
SCHEMBL535467 0.76 LMNA (0.42) LMNASMN1; SMN2HPGDTSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1747 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-B1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2009-04-01 EP claimed
US-7196110-B2 N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders JANSSEN PHAMACEUTICA N.V. (BE) 2007-03-27 US claimed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP claimed
US-20040082639-A1 N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders JANSSEN PHARMACEUTICA, N.V. (BE) 2004-04-29 US claimed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO claimed
EP-0354297-B1 THIADIAZINES, PROCESS FOR PRODUCTION THEREOF, AND INSECTICIDAL AND ACARICIDAL AGENTS COMPRISING THE THIADIAZINES MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-08-05 EP claimed
US-4113495-A 2,4,4-TRIMETHYL-2-(2,5-DIHYDROXYPHENYL)-6-HYDROXY-CHROMANS FUJI PHOTO FILM CO., LTD. (JP) 1978-09-12 US claimed
US-3991042-A Basic azo dyestuffs containing a benzthiazole and a tetrahydroquinoline nucleus BAYER AKTIENGESELLSCHAFT (DT) 1976-11-09 US claimed
US-3948877-A POLYACRYLONITRILE, ACID MODIFIED POLYESTERS OR POLYAMIDES BAYER AKTIENGESELLSCHAFT (DT) 1976-04-06 US claimed
CN-118202006-A Resin composition, cured product, optical member, ultraviolet absorber, compound, method for producing compound, and polymer 富士胶片株式会社 2024-06-14 CN disclosed
CN-118176445-A Light absorbing filter, light filter, method for manufacturing light absorbing filter, organic electroluminescent display device, inorganic electroluminescent display device, and liquid crystal display device 富士胶片株式会社 2024-06-11 CN disclosed
US-11993697-B2 Flexible tube for endoscope, endoscopic medical device, and resin composition for covering flexible tube substrate for endoscope FUJIFILM CORPORATION (JP) 2024-05-28 US disclosed
CN-115135643-B Compound and organic light emitting device including the same 株式会社LG化学 2024-04-30 CN disclosed
WO-2024085172-A1 LIGHT ABSORPTION FILTER, OPTICAL FILTER AND METHOD FOR PRODUCING SAME, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, INORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE 富士フイルム株式会社 2024-04-25 WO disclosed
US-4367272-A MORDANTS, REFLECTION FUJI PHOTO FILM CO., LTD (JP) 1983-01-04 US disclosed
US-4266020-A XANTHENES AS DISCOLORATION INHIBITORS FUJI PHOTO FILM CO., LTD. (JP) 1981-05-05 US disclosed
US-4264720-A CHROMENE COMPOUND COLOR STABILIZING AGENT FUJI PHOTO FILM CO., LTD. (JP) 1981-04-28 US disclosed
US-4259350-A PROTECTING DEGRADABLE ORGANIC MATERIAL FROM FUNGAL OR INSECT ATTACK SANKYO COMPANY LIMITED (JP) 1981-03-31 US disclosed
US-4202816-A ENOL-PIPERIDINE METAL COMPLEXES CIBA-GEIGY CORPORATION (US) 1980-05-13 US disclosed
US-4113495-A 2,4,4-TRIMETHYL-2-(2,5-DIHYDROXYPHENYL)-6-HYDROXY-CHROMANS FUJI PHOTO FILM CO., LTD. (JP) 1978-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082639-A1 N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders PDGFRA, PDGFRB, PDGFA LMNA 2824/4885SMN1; SMN2 4012/4885HPGD 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.